Sivraj Muralikrishnan
0000-0001-5465-9562
2 papers found
Refreshing results…
A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL
Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice
Missing publications? Search for publications with a matching author name.